TBIO
Price:
$0.3
Market Cap:
$532.75K
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop r...[Read more]
Industry
Medical - Devices
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
TBIO
According to Telesis Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.10M. This represents a change of -90.68% compared to the average of 140.66M of the last 4 quarters.
The mean historical Enterprise Value of Telesis Bio, Inc. over the last ten years is 8.06B. The current 13.10M Enterprise Value has changed -83.75% with respect to the historical average. Over the past ten years (40 quarters), TBIO's Enterprise Value was at its highest in in the December 2019 quarter at 19.91B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.
Average
8.06B
Median
9.81B
Minimum
247.13M
Maximum
14.93B
Discovering the peaks and valleys of Telesis Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.91%
Maximum Annual Enterprise Value = 14.93B
Minimum Annual Increase = -88.86%
Minimum Annual Enterprise Value = 247.13M
Year | Enterprise Value | Change |
---|---|---|
2023 | 247.13M | -60.61% |
2022 | 627.42M | -88.86% |
2021 | 5.63B | -42.08% |
2020 | 9.73B | -28.20% |
2019 | 13.55B | -9.26% |
2018 | 14.93B | 50.91% |
2017 | 9.89B | 0.10% |
The current Enterprise Value of Telesis Bio, Inc. (TBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.17B
5-year avg
5.96B
10-year avg
8.06B
Telesis Bio, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telesis Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telesis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Telesis Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Telesis Bio, Inc. (TBIO)?
What is the 3-year average Enterprise Value for Telesis Bio, Inc. (TBIO)?
What is the 5-year average Enterprise Value for Telesis Bio, Inc. (TBIO)?
How does the current Enterprise Value for Telesis Bio, Inc. (TBIO) compare to its historical average?